AAAAAA
Results: 1-25/50
Authors:
Levin, NW
Hoenich, NA
Citation: Nw. Levin et Na. Hoenich, Consequences of hyperphosphatemia and elevated levels of the calcium-phosphorus product in dialysis patients, CURR OP NEP, 10(5), 2001, pp. 563-568
Authors:
Ganesh, SK
Stack, AG
Levin, NW
Hulbert-Shearon, T
Port, FK
Citation: Sk. Ganesh et al., Association of elevated serum PO4, Ca x PO4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients, J AM S NEPH, 12(10), 2001, pp. 2131-2138
Authors:
Schneditz, D
Zaluska, WT
Morris, AT
Levin, NW
Citation: D. Schneditz et al., Effect of ultrafiltration on peripheral urea sequestration in haemodialysis patients, NEPH DIAL T, 16(5), 2001, pp. 994-998
Authors:
Levin, NW
Ronco, C
Citation: Nw. Levin et C. Ronco, Haemodialysis renal replacement therapy - do we need more research?, NEPH DIAL T, 16(4), 2001, pp. 698-700
Authors:
Schneditz, D
Levin, NW
Citation: D. Schneditz et Nw. Levin, Keep your temper: how to avoid heat accumulation in haemodialysis, NEPH DIAL T, 16(1), 2001, pp. 7-9
Authors:
Hoenich, NA
Levin, NW
Citation: Na. Hoenich et Nw. Levin, Are standards for dialysate purity in hemodialysis insufficiently strict?, SEMIN DIAL, 14(5), 2001, pp. 329-331
Authors:
Winchester, JF
Brady, JA
Ronco, C
Yousha, E
Smith, A
Clemmer, J
Muller, TE
La Greca, G
Levin, NW
Citation: Jf. Winchester et al., The role of middle molecules in uremia - Preliminary report of an international survey of nephrologists and scientists, CONTR NEPHR, 133, 2001, pp. 23-27
Authors:
Winchester, JF
Ronco, C
Brady, JA
Clemmer, J
Muller, TE
Davankov, V
Tsyurupa, M
Pavlova, L
Pavlov, M
Levin, NW
Citation: Jf. Winchester et al., History of sorbents in uremia, CONTR NEPHR, 133, 2001, pp. 131-139
Authors:
Ronco, C
Brendolan, A
Winchester, JF
Golds, E
Clemmer, J
Polaschegg, HD
Muller, TE
Davankov, V
Tsyurupa, M
Pavlova, L
Pavlov, M
La Greca, G
Levin, NW
Citation: C. Ronco et al., First clinical experience with an adjunctive hemoperfusion device designedspecifically to remove beta(2)-microglobulin in hemodialysis, CONTR NEPHR, 133, 2001, pp. 166-173
Authors:
Winchester, JF
Ronco, C
Brady, JA
Brendolan, A
Davankov, V
Tsyurupa, M
Pavlova, L
Pavlov, M
Clemmer, J
Polaschegg, HD
Muller, TE
La Greca, G
Levin, NW
Citation: Jf. Winchester et al., Rationale for combined hemoperfusion/hemodialysis in uremia, CONTR NEPHR, 133, 2001, pp. 174-179
Authors:
Spittle, MA
Hoenich, NA
Handelman, GJ
Adhikarla, R
Homel, P
Levin, NW
Citation: Ma. Spittle et al., Oxidative stress and inflammation in hemodialysis patients, AM J KIDNEY, 38(6), 2001, pp. 1408-1413
Authors:
Eknoyan, G
Levin, NW
Eschbach, JW
Golper, TA
Owen, WF
Schwab, S
Steinberg, EP
Citation: G. Eknoyan et al., Continuous quality improvement: DOQI becomes K/DOQI and is updated, AM J KIDNEY, 37(1), 2001, pp. 179-180
Authors:
Levin, NW
Owen, WF
Citation: Nw. Levin et Wf. Owen, Urban Renal Disease - Introduction, SEM NEPHROL, 21(4), 2001, pp. 327-328
Authors:
Levin, NW
Ronco, C
Citation: Nw. Levin et C. Ronco, Advances in end-stage renal diseases 2001 - International Conference on Dialysis III, January 18-19, 2001, Miami Beach, Fla. - Preface, BLOOD PURIF, 19(2), 2001, pp. 137-138
Authors:
Levin, NW
Zhu, FS
Keen, M
Citation: Nw. Levin et al., Interdialytic weight gain and dry weight, BLOOD PURIF, 19(2), 2001, pp. 217-221
Authors:
Rahmati, S
Ronco, F
Spittle, M
Morris, AT
Schleper, C
Rosales, L
Kaufman, A
Amerling, R
Ronco, C
Levin, NW
Citation: S. Rahmati et al., Validation of the blood temperature monitor for extracorporeal thermal energy balance during in vitro continuous hemodialysis, BLOOD PURIF, 19(2), 2001, pp. 245-250
Authors:
Winchester, JF
Ronco, C
Brady, JA
Golds, E
Clemmer, J
Cowgill, LD
Levin, NW
Citation: Jf. Winchester et al., Sorbent augmented dialysis: Minor addition or major advance in therapy?, BLOOD PURIF, 19(2), 2001, pp. 255-259
Authors:
Ronco, C
Brendolan, A
Winchester, JF
Golds, E
Clemmer, J
Polaschegg, HD
Muller, TE
La Greca, G
Levin, NW
Citation: C. Ronco et al., First clinical experience with an adjunctive hemoperfusion device designedspecifically to remove beta(2)-microglobulin in hemodialysis, BLOOD PURIF, 19(2), 2001, pp. 260-263
Authors:
Kaysen, GA
Dubin, JA
Muller, HG
Mitch, WE
Levin, NW
Citation: Ga. Kaysen et al., Levels of alpha 1 acid glycoprotein and ceruloplasmin predict future albumin levels in hemodialysis patients, KIDNEY INT, 60(6), 2001, pp. 2360-2366
Authors:
Kaysen, GA
Chertow, GM
Adhikarla, R
Young, B
Ronco, C
Levin, NW
Citation: Ga. Kaysen et al., Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialysis patients, KIDNEY INT, 60(1), 2001, pp. 333-340
Authors:
Handelman, GJ
Walter, MF
Adhikarla, R
Gross, J
Dallal, GE
Levin, NW
Blumberg, JB
Citation: Gj. Handelman et al., Elevated plasma F2-isoprostanes in patients on long-term hemodialysis, KIDNEY INT, 59(5), 2001, pp. 1960-1966
Authors:
Eknoyan, G
Levey, AS
Levin, NW
Keane, WF
Citation: G. Eknoyan et al., The national epidemic of chronic kidney disease - What we know and what wecan do, POSTGR MED, 110(3), 2001, pp. 23-29
Authors:
Ronco, C
Ghezzi, PM
Metry, G
Spittle, M
Brendolan, A
Rodighiero, M
Milan, M
Zanella, M
La Greca, G
Levin, NW
Citation: C. Ronco et al., Effects of hematocrit and blood flow distribution on solute clearance in hollow-fiber hemodialyzers, NEPHRON, 89(3), 2001, pp. 243-250
Authors:
Boorgu, R
Dubrow, AJ
Levin, NW
My, H
Canaud, BJ
Lentino, JR
Wentworth, DW
Hatch, DA
Megerman, J
Prosl, FR
Gandhi, VC
Ing, TS
Citation: R. Boorgu et al., Adjunctive antibiotic/anticoagulant lock therapy in the treatment of bacteremia associated with the use of a subcutaneously implanted hemodialysis access device, ASAIO J, 46(6), 2000, pp. 767-770
Authors:
Amerling, R
Ronco, C
Levin, NW
Citation: R. Amerling et al., Continuous-flow peritoneal dialysis, PERIT DIA I, 20, 2000, pp. S172-S177